Gastrointestinal stromal tumours (GIST) - 17 years experience from Mid Trent Region (United Kingdom)

被引:46
作者
Ahmed, I. [1 ]
Welch, N. T. [1 ]
Parsons, S. L. [1 ]
机构
[1] City Hosp Nottingham, Dept Gen & Upper GI Surg, Nottingham NG5 1PB, England
来源
EJSO | 2008年 / 34卷 / 04期
关键词
GIST; gastrointestinal stromal tumour; CD117; resection margins; recurrence;
D O I
10.1016/j.ejso.2007.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Objectives: To report our experience with gastrointestinal stromal tumours (GISTs). Methods: Retrospective data were collected from January 1987 to December 2003. Clinical and histological data were analysed to identify recurrence patterns and factors predicting survival. The tumours were studied with respect to size, number of mitosis and cell type. Results: One hundred and eighty-five patients were identified with GIST with the age range of 18-93 years (mean 64.4 years) with a mean follow up of 6.7 years. Eighty out of 185 patients were in the low group, 38/185 in intermediate risk and 67/185 were in the high risk group. Eighty-three percent of the patients underwent surgical resection. Ten percent of the patients in the intermediate group and 25% of the patients in high risk group developed recurrence. Mortality was 5% and 37% in intermediate and high risk groups, respectively. There was no tumour related mortality or recurrence in the low risk group. Conclusions: It is important to identify the patients in low and high risk groups. Patients in intermediate and high risk groups require complete resection (R0) and follow up with CT scans. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:445 / 449
页数:5
相关论文
共 27 条
[1]
Gastrointestinal stromal tumours [J].
Connolly, EM ;
Gaffney, E ;
Reynolds, JV .
BRITISH JOURNAL OF SURGERY, 2003, 90 (10) :1178-1186
[2]
Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival [J].
DeMatteo, RP ;
Lewis, JJ ;
Leung, D ;
Mudan, SS ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 2000, 231 (01) :51-58
[3]
Clinical management of gastrointestinal stromal tumors: Before and after STI-571 [J].
DeMatteo, RP ;
Heinrich, MC ;
El-Rifai, WM ;
Demetri, G .
HUMAN PATHOLOGY, 2002, 33 (05) :466-477
[5]
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].
Demetri, GD ;
von Mehren, M ;
Blanke, CD ;
Van den Abbeele, AD ;
Eisenberg, B ;
Roberts, PJ ;
Heinrich, MC ;
Tuveson, DA ;
Singer, S ;
Janicek, M ;
Fletcher, JA ;
Silverman, SG ;
Silberman, SL ;
Capdeville, R ;
Kiese, B ;
Peng, B ;
Dimitrijevic, S ;
Druker, BJ ;
Corless, C ;
Fletcher, CDM ;
Joensuu, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480
[6]
Diagnosis of gastrointestinal stromal tumors: A consensus approach [J].
Fletcher, CDM ;
Berman, JJ ;
Corless, C ;
Gorstein, F ;
Lasota, J ;
Longley, BJ ;
Miettinen, M ;
O'Leary, TJ ;
Remotti, H ;
Rubin, BP ;
Shmookler, B ;
Sobin, LH ;
Weiss, SW .
HUMAN PATHOLOGY, 2002, 33 (05) :459-465
[7]
Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: Analysis of results in 140 surgically resected patients [J].
Yoshiya Fujimoto ;
Yukihiro Nakanishi ;
Kimio Yoshimura ;
Tadakazu Shimoda .
Gastric Cancer, 2003, 6 (1) :39-48
[8]
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors [J].
Hirota, S ;
Isozaki, K ;
Moriyama, Y ;
Hashimoto, K ;
Nishida, T ;
Ishiguro, S ;
Kawano, K ;
Hanada, M ;
Kurata, A ;
Takeda, M ;
Tunio, GM ;
Matsuzawa, Y ;
Kanakura, Y ;
Shinomura, Y ;
Kitamura, Y .
SCIENCE, 1998, 279 (5350) :577-580
[9]
JUDONS I, 2002, SARCOMA, V6, P83
[10]
Kindblom LG, 1998, AM J PATHOL, V152, P1259